Search All Resources
Medication Management of Depression | May 17, 2023
In this presentation, Dr. Jasen Christensen, DO, discusses the range of antidepressants available, reasons to choose and reasons to avoid certain antidepressants, and reviews the importance of antidepressant treatment duration.
Date added: 05/17/23
State of Hep C 2023 | May 3, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #hepatitis c #insurance #prior authorization #restrictions
In this presentation, Dr. Richard Manch, MD, provides a comprehensive overview and update of the latest HCV Treatment Restrictions Data from all 50 state Medicaid programs. Hepatitis C is our nation’s deadliest bloodborne infectious disease, yet many state Medicaid programs ...
Date added: 04/30/23
HCV 101: Medications and Management | April 26, 2023
Type: Past Presentation Training
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #hcv cure #hcv treatment #hep c #hepatitis
In this training, Dr. Paulina Deming discusses treatment and management of patients with hepatitis C in primary care, including medications, approaches to treatment, medication interactions, and treatment monitoring.
Date added: 04/26/23
Supporting Pregnant and Parenting People Experiencing SUDs | April 19, 2023
Type: Past Presentation
Audience: Clinical Community
Program: Hepatitis C
Keywords: #parents #pregnancy #pregnant #substance use disorder #SUD #SUD treatment
In this series of presentation, Dr Sherry Daker, PharmD, MHA, Treatment and Recovery Co-Lead for the IHS National Committee on Heroin, Opioids & Pain Efforts, highlights best practices for supporting pregnant and parenting people, partners, and families experiencing substance use disorders. ...
Date added: 04/17/23
Diabetes and HCV | April 5, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #diabetes #dm #hcc #hcv and diabetes #hepatitis c #hepatocellular carcinoma #type 2 diabetes
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV & insulin resistance, how HCV can potentially induce or aggravate ...
Date added: 04/3/23
Substance Use and Injecting Behaviors During and After Hepatitis C Treatment Among Persons Who Inject Drugs | March 22, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cure #hcv #pwid #substance use
In this presentation, Kimberly Page, PhD, MPH, Professor of Epidemiology at The University of New Mexico, describes injection practices among people who inject drugs (PWID) before, during, and after HCV treatment with DAAs. Dr Page also examines whether sharing injecting ...
Date added: 03/20/23
Medications for Alcohol Use Disorder | March 15, 2023
In this presentation, Dr. Jasen Christensen, DO, discusses the FDA-approved and off-label medications for alcohol use disorder, shares the evidence supporting each medication and provides tangible ways to apply treatments to appropriate cases.
Date added: 03/15/23
Safer Sex Pocketbook
Type: Download Handouts
Audience: Clinical Community
Program: Infectious Disease ECHO Program Hepatitis C HIV ECHO Program
Keywords: #patient education #safe sex #sexually transmitted infections #STIs
This handy pocketbook developed by the Northwest Portland Area Indian Health Board contains the essential information about safe sex, including how and why.
Date added: 03/13/23
Hepatitis C Pocketbook
Type: Download Handouts
Audience: Clinical Community
Program: Infectious Disease ECHO Program Hepatitis C
Keywords: #hcv #hepatitis c #patient education #sexually transmitted infections #STIs
This handy pocketbook developed by the Northwest Portland Area Indian Health Board contains the essential information about hepatitis C, including the basics of hep C treatment, risk, and symptoms.
Date added: 03/13/23
NASH Update 2023 | March 1, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #aasld #fatty liver #hepatitis #liver #nafl #NAFLD #NASH
In this presentation, Dr. Richard Manch, MD, provides a comprehensive overview and update as it relates to Nonalcoholic Fatty Liver Disease (NAFLD) and particularly, Nonalcoholic Steatohepatitis (NASH). Furthermore, Dr. Manch provides an American Association for the Study of Liver Diseases ...
Date added: 03/1/23